Blog
72 Articles
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
Planning for My Future
When diagnosed with Stage IV PNET at the age of 30, Amy Zaterman found a doctor who believed in her and didn’t give up. Learn more about her inspiring story.
A Second Opinion Changes the Pancreatic Cancer Game Plan
Gregg Wittman’s doctors diagnosed him with stage IV pancreatic cancer, but could never get a good biopsy; a second opinion figured out the reason.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
Each Person Is a Statistic of One
When Miggie Olsson was diagnosed with stage IV pancreatic cancer she opted for a science-based unusual treatment plan to have a chance at survival.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
I’ll Never Stop Fighting
When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.
After Surviving Pancreatic Cancer, a Moral Obligation to Share
Tom Dinwiddie knew he needed surgery to survive stage IV neuroendocrine pancreatic cancer; he got a new protocol of treatment before surgery.
My Journey Through Stage IV Pancreatic Cancer
When Chris Parrish was diagnosed with stage IV pancreatic cancer, she searched for a program and treatment plan until she found a place that gave her hope.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.
Facing Pancreatic Cancer and Making the Most of Borrowed Time
With a young family, Justin Baker is hoping for more time because he has a genetic mutation that favors certain treatments.
Choosing the Strongest Chemotherapy for Pancreatic Cancer
Miriam Hermosa decided to take advantage of her relatively good health and try pancreatic cancer treatment with FOLFIRINOX to get more time with her family.
A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
Molecular Sequencing Leads to Customized Treatment
When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.
A Charley Horse Led to Pancreatic Neuroendocrine Tumor Discovery
Mark Head thought he had a Charley horse, but it turned out to be a more serious deep vein thrombosis. A scan for the source found a pancreatic neuroendocrine tumor.